1
|
Interpretative problems and preparative technique influence reliability of intraoperative parathyroid touch imprints.
|
Arch Pathol Lab Med
|
2003
|
2.02
|
2
|
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
|
Cancer
|
2007
|
1.73
|
3
|
Primary osteosarcoma of the breast: report of 2 cases.
|
Arch Pathol Lab Med
|
2007
|
1.55
|
4
|
Imaging features of micropapillary DCIS: correlation with clinical and histopathological findings.
|
Acad Radiol
|
2011
|
1.39
|
5
|
Pathological examination of sentinel lymph node in breast cancer: potential problems and possible solutions.
|
Microsc Res Tech
|
2002
|
1.38
|
6
|
Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases.
|
Mod Pathol
|
2007
|
1.33
|
7
|
Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings.
|
Breast Cancer Res Treat
|
2007
|
1.31
|
8
|
Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma.
|
Appl Immunohistochem Mol Morphol
|
2007
|
1.29
|
9
|
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
|
J Nucl Med
|
2009
|
1.29
|
10
|
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
|
Clin Cancer Res
|
2006
|
1.21
|
11
|
Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.
|
Hum Pathol
|
2011
|
1.14
|
12
|
Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
|
Cancer
|
2006
|
1.07
|
13
|
Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast.
|
Am J Surg Pathol
|
2012
|
0.94
|
14
|
Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.
|
Ann Surg Oncol
|
2014
|
0.93
|
15
|
Loss of annexin A1 expression in breast cancer progression.
|
Appl Immunohistochem Mol Morphol
|
2008
|
0.89
|
16
|
Malignant transformation of adenomyoepithelioma of the breast by a monophasic population: a report of two cases and review of literature.
|
APMIS
|
2012
|
0.88
|
17
|
Preoperative diagnosis of clear cell "sugar" tumor of the lung by computed tomography-guided fine-needle biopsy and core-needle biopsy.
|
Ann Diagn Pathol
|
2007
|
0.86
|
18
|
Cytologic features of renal medullary carcinoma.
|
Cancer
|
2005
|
0.85
|
19
|
Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
|
Histopathology
|
2011
|
0.83
|
20
|
Primary gastrointestinal stromal tumor of the esophagus in an HIV-positive patient.
|
Ann Diagn Pathol
|
2005
|
0.82
|
21
|
Megakaryocytes mimicking metastatic breast carcinoma.
|
Arch Pathol Lab Med
|
2002
|
0.82
|
22
|
Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.
|
Pathol Res Pract
|
2010
|
0.81
|
23
|
Trastuzumab administration associated with change in HER2 status.
|
Clin Breast Cancer
|
2008
|
0.81
|
24
|
Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.
|
Histopathology
|
2012
|
0.80
|
25
|
A large, fungating breast mass. Secretory carcinoma with apocrine differentiation.
|
Arch Pathol Lab Med
|
2006
|
0.79
|
26
|
Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast.
|
J Clin Pathol
|
2010
|
0.78
|
27
|
Giant cell tumor of soft tissue arising in breast.
|
Ann Diagn Pathol
|
2007
|
0.75
|
28
|
Is it too soon to start reporting HER2 genetic heterogeneity?
|
Arch Pathol Lab Med
|
2010
|
0.75
|
29
|
Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up.
|
Chin J Cancer
|
2014
|
0.75
|
30
|
Androgen Receptor (AR) Expression in Invasive Male Breast Carcinoma (MBC): An International Multi-Institutional Review of 168 Cases Emphasizing the Potential Use of AR as a Therapeutic Target.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.75
|
31
|
Androgen Receptor (AR) Expression in Invasive Male Breast Carcinoma (MBC): An International Multi-Institutional Review of 168 Cases Emphasizing the Potential Use of AR as a Therapeutic Target.
|
Appl Immunohistochem Mol Morphol
|
2017
|
0.75
|